Monday, December 04, 2023 1:26:44 PM
At 11:48am today the AVXL share price hit $8.18; an 8.06% gain for the day. What’s driving this steep share price ascent? “The market” or “the street” seem to be taking on new perspectives concerning Anavex Life Sciences Corp.
Here’s something that people with both potential and existing AVXL positions, just for fun (presently) should try. I just did it, and in every one of my iterations the final numbers were, well, phenomenal.
What are the potential values related to the holding of AVXL equities? What might future dividends and share values be? More importantly, what could be the actual ranges for these metrics? Here’s how I determined those.
On a spreadsheet, or with a calculator and a sheet of paper, try setting down various values. Here’s the ones I plugged in (but I won’t give the numbers I assigned to each –- that’s something for each AVXL investor to do).
In cell 1A, enter “Number of Barcamesine Patients.” In cell 2A, write in the number of patients you think will be treated in a given year.
In cell 2A, enter “Daily Drug Cost.” In cell 2B, enter the dollar amount you estimate a day’s treatment with blarcamesine will cost.
In cell 3A, enter “Annual ANAVEX Revenues.” In cell 3B, enter the formula =b1*365
In cell 4A, enter “Dividend Dropdown %.” In cell 4B enter the percent of annual revenues that you estimate will go out as dividends. If you think 5% of annual revs will go out as dividends, enter “0.05.”
In cell 5A, enter “Total Dividends Distributed.” In cell 5B, enter the formula “=b3*b4.”
In cell 6A, enter “No. of AVXL Shares.” In cell 6B, enter the number of AVXL shares in circulation. In my calculations, I used “100,000,000.” Presently, there are 81,950,000 AVXL shares.
In cell 7A, enter “Annual Per-share Dividend.” In cell 7B, enter the formula “=b5/b6.”
In cell 8A, enter “Owned Shares.” In cell 8B, enter the number of AVXL shares you own or will purchase.
In cell 9A, enter “My Annual Dividends.” In cell 9B, enter the formula “=b7*b8.”
In cell 10A, enter “Estimated P:E Ratio.” In cell 10B, enter a number you think is the price to earnings ratio number. A “20" will indicate that that the share price will be 20x the dividend.
Finally, in cell 11A, enter “Value of My AVXL Holding.” In cell 11B, enter the formula “=10b*8b.”
***********
Personally, I’ve accumulated over the years several thousand AVXL shares, presently with an 83% value gain. If Anavex is able to treat only a few hundred thousand patients a year, with very moderate $1000/year drug costs to the patient or insurance company, I and my beneficiaries are going to be very comfortable.
Are you considering the taking of an AVXL equity position? Plug in these numbers and see what a $500 dollar purchase of AVXLs might be worth in five years, when blarcamesine will actually be treating millions of people with CNS and other diseases.
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM